Literature DB >> 10506840

[Severe cholestasis with kidney failure from anabolic steroids in a body builder].

W Habscheid1, U Abele, H H Dahm.   

Abstract

HISTORY AND ADMISSION
FINDINGS: A 28-year-old body builder was admitted because of jaundice. For 80 days, until 3 weeks before hospitalization, he had been taking moderately high doses of anabolic steroids: metandienone (methandienone), 10-50 mg daily by mouth, and stanozolol, 50 mg intramuscularly every other day. Physical examination was unremarkable except for yellow discoloration of the skin and sclerae. INVESTIGATIONS: Bilirubin concentration was raised to 4.5 mg/dl, cholestasis enzymes were normal, while transaminase activities were raised. Liver biopsy was compatible with cholestasis induced by anabolic steroids. TREATMENT AND COURSE: Although the steroids had been discontinued, the patient's general condition deteriorated over 7 weeks. Serum bilirubin rose up to a maximum of 77.9 mg/dl. In addition renal failure developed with a creatinine concentration of 4.2 mg/dl. The patient's state improved simultaneously with the administration of ursodeoxycholic acid and the biochemical values gradually reached normal levels after several weeks.
CONCLUSION: Anabolic steroids can cause severe cholestasis and acute renal failure. In this case there was a notable temporal coincidence between the administration of ursodeoxycholic acid and the marked clinical improvement.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506840     DOI: 10.1055/s-2007-1024477

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  5 in total

1.  Toxic hepatitis after sequential administration of flutamide and cyproterone acetate.

Authors:  Spilios Manolakopoulos; Sotirios Bethanis; Anastasios Armonis; Michalis Economou; Alec Avgerinos; Dimitrios Tzourmakliotis
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

2.  Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.

Authors:  Nawed Deshmukh; Andrea Petróczi; James Barker; Andrea D Székely; Iltaf Hussain; Declan P Naughton
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-04-29

Review 3.  Acute kidney injury due to anabolic steroid and vitamin supplement abuse: report of two cases and a literature review.

Authors:  Elizabeth F Daher; Geraldo B Silva Júnior; Anaiara L Queiroz; Lysiane M A Ramos; Silvia Q Santos; Dulce M S Barreto; Antonio Augusto C Guimarães; Célio A Barbosa; Luciano M Franco; Régia M S V Patrocínio
Journal:  Int Urol Nephrol       Date:  2009-04-23       Impact factor: 2.370

4.  Mastabol induced acute cholestasis: A case report.

Authors:  Brett M Hymel; David W Victor; Luis Alvarez; Nathan J Shores; Luis A Balart
Journal:  World J Hepatol       Date:  2013-03-27

5.  Severe intrahepatic cholestasis and liver failure after stanozolol usage - case report and review of the literature.

Authors:  Piotr M Stępień; Katarzyna Reczko; Anna Wieczorek; Dorota Zarębska-Michaluk; Paweł Pabjan; Teodora Król; Wiesław Kryczka
Journal:  Clin Exp Hepatol       Date:  2015-04-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.